Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
Clinical trial NCT05740943 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05740943
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2025-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.